Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Alumis Inc | 5,779,348 | 5,779,348 | 0 | $45.43M | $35.49M | 40.50% | -$9.94M |
| CG Oncology, Inc.(CGON) | 692,550 | 859,050 | +166,500 | $19.86M | $21.04M | 24.01% | +$1.18M |
| Disc Medicine, Inc.(IRON) | 299,069 | 299,069 | 0 | $18.96M | $14.85M | 16.94% | -$4.12M |
| Hims & Hers Health, Inc.CL A(HIMS) | 939,860 | 273,151 | -666,709 | $22.73M | $8.07M | 9.21% | -$14.65M |
| Lyell Immunopharma, Inc.(LYEL) | 8,133,047 | 8,133,047 | 0 | $5.21M | $4.38M | 4.99% | -$829.6K |
| Maze Therapeutics, Inc.(MAZE) | 0 | 345,191 | +345,191 | $0 | $3.80M | 4.34% | +$3.80M |
| Cullinan Therapeutics, Inc.(CGEM) | 657,905 | 0 | -657,905 | $8.01M | $0 | — | -$8.01M |